Cooper Companies | COO - Ebitda


Cooper Companies reported $323.4M in EBITDA for its fiscal quarter ending in December of 2025.





Ebitda Change Date
Abbott USD 3.27B 178M Dec/2025
Align Technology USD 260.87M 77.03M Dec/2025
AtriCure USD 17.07M 2.79M Mar/2026
Avanos Medical USD 13M 3M Dec/2025
Bausch Health Companies USD 837M 94M Mar/2026
Baxter International USD -447M 873M Dec/2025
Bayer EUR 4.45B 2.49B Mar/2026
Becton, Dickinson and Co. USD 1.71B 433M Dec/2025
Boston Scientific USD 1.16B 213M Dec/2025
Cooper Companies USD 323.4M 13.2M Dec/2025
Dentsply International USD 129M 6M Mar/2026
Dexcom USD 364.5M 57.7M Mar/2026
Edwards Lifesciences USD 70.1M 394.2M Dec/2025
Globus Medical USD 280.46M 27.86M Dec/2025
Haemonetics USD 94.78M 20.75M Dec/2025
Insulet USD 181.7M 12.3M Mar/2026
Integra LifeSciences USD 76.18M 28.03M Mar/2026
Intuitive Surgical USD 1.09B 165.5M Dec/2025
J&J USD 8.27B 1.08B Mar/2026
Medtronic USD 2.81B 119M Mar/2026
Merit Medical Systems USD 97.23M 17.69M Dec/2025
Novartis USD 5.41B 431M Mar/2026
ResMed USD 547.48M 27.46M Dec/2025
STAAR Surgical USD -159K 34.78M Dec/2025
Steris USD 394.7M 5M Dec/2025
Stryker USD 1.57B 618M Mar/2026
Tandem Diabetes Care USD 2.73M 30.17M Mar/2026
Teleflex USD 247.07M 575.88M Dec/2025
Zimmer Biomet Holdings USD 759M 120.8M Dec/2025